nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apolipoprotein A-I and risk for cardiovascular diseases
|
Khuseyinova, Natalie |
|
2006 |
8 |
5 |
p. 365-373 |
artikel |
2 |
Are lower levels of low-density lipoprotein cholesterol beneficial? A review of recent data
|
Olsson, Anders G. |
|
2006 |
8 |
5 |
p. 382-389 |
artikel |
3 |
Clinical insights into the diagnosis and management of atherosclerotic renal artery disease
|
Bloch, Michael J. |
|
2006 |
8 |
5 |
p. 412-420 |
artikel |
4 |
Clinical Trials Report
|
Toth, Peter P. |
|
2006 |
8 |
5 |
p. 353-355 |
artikel |
5 |
Complex “Cross Talk” Involving Nitric Oxide Metabolites: Who’s Listening?
|
Hajjar, David P. |
|
2006 |
8 |
5 |
p. 347-348 |
artikel |
6 |
C-reactive protein and cardiovascular disease: Weighing the evidence
|
Lowe, Gordon D. O. |
|
2006 |
8 |
5 |
p. 421-428 |
artikel |
7 |
Fibrate therapy in patients with metabolic syndrome and diabetes mellitus
|
Dayspring, Thomas |
|
2006 |
8 |
5 |
p. 356-364 |
artikel |
8 |
High-density lipoprotein: Is it always atheroprotective?
|
Ansell, Benjamin J. |
|
2006 |
8 |
5 |
p. 405-411 |
artikel |
9 |
Hypoadiponectinemia: A common basis for diseases associated with overnutrition
|
Funahashi, Tohru |
|
2006 |
8 |
5 |
p. 433-438 |
artikel |
10 |
Impact of thiazolidenediones on serum lipoprotein levels
|
Goldberg, Ronald B. |
|
2006 |
8 |
5 |
p. 397-404 |
artikel |
11 |
Lipoprotein-associated phospholipase A2: Pathogenic mechanisms and clinical utility for predicting cardiovascular events
|
Nambi, Vijay |
|
2006 |
8 |
5 |
p. 374-381 |
artikel |
12 |
Statins and the primary prevention of cardiovascular events
|
Clearfield, Michael |
|
2006 |
8 |
5 |
p. 390-396 |
artikel |
13 |
The CARDS trial: Diabetic patients dealt a winning hand
|
Armani, Annemarie |
|
2006 |
8 |
5 |
p. 429-432 |
artikel |
14 |
Web alert
|
Chilton, Robert |
|
2006 |
8 |
5 |
p. 349 |
artikel |